- Home
- WMPN vs NVCT Comparison
WMPN vs NVCT Comparison
Compare WMPN & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WMPN
- NVCT
- Stock Information
- Founded
- WMPN 1870
- NVCT 2020
- Country
- WMPN United States
- NVCT United States
- Employees
- WMPN N/A
- NVCT N/A
- Industry
- WMPN Savings Institutions
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- WMPN Finance
- NVCT Health Care
- Exchange
- WMPN Nasdaq
- NVCT Nasdaq
- Market Cap
- WMPN 119.5M
- NVCT 119.4M
- IPO Year
- WMPN N/A
- NVCT 2022
- Fundamental
- Price
- WMPN $12.27
- NVCT $4.52
- Analyst Decision
- WMPN Buy
- NVCT Strong Buy
- Analyst Count
- WMPN 1
- NVCT 1
- Target Price
- WMPN $14.00
- NVCT $21.00
- AVG Volume (30 Days)
- WMPN 17.5K
- NVCT 94.6K
- Earning Date
- WMPN 01-15-2025
- NVCT 11-05-2024
- Dividend Yield
- WMPN 0.98%
- NVCT N/A
- EPS Growth
- WMPN N/A
- NVCT N/A
- EPS
- WMPN N/A
- NVCT N/A
- Revenue
- WMPN $20,360,000.00
- NVCT N/A
- Revenue This Year
- WMPN N/A
- NVCT N/A
- Revenue Next Year
- WMPN N/A
- NVCT N/A
- P/E Ratio
- WMPN N/A
- NVCT N/A
- Revenue Growth
- WMPN N/A
- NVCT N/A
- 52 Week Low
- WMPN $10.80
- NVCT $4.44
- 52 Week High
- WMPN $13.87
- NVCT $12.10
- Technical
- Relative Strength Index (RSI)
- WMPN 30.30
- NVCT 37.50
- Support Level
- WMPN $12.77
- NVCT $4.48
- Resistance Level
- WMPN $12.93
- NVCT $5.34
- Average True Range (ATR)
- WMPN 0.27
- NVCT 0.37
- MACD
- WMPN -0.13
- NVCT 0.07
- Stochastic Oscillator
- WMPN 0.00
- NVCT 8.89
About WMPN William Penn Bancorporation
William Penn Bancorporation operates as an independent community financial services provider. The bank offers traditional banking and related financial services to individual, business, and government customers. Through its branch and automated teller machine network, the bank offers a full array of commercial and retail financial services, including; the taking of time, savings, and demand deposits; the making of commercial, consumer, and mortgage loans; and the providing of other financial services.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.